Advertisement
Advertisement

HIV Management In Depth
HIV Management in Depth: A Podcast Series Exploring Key Issues in HIV Care
From TheBodyPRO.com
David Harrich, Ph.D.
Featuring David Harrich, Ph.D.
Gene therapy is one of several avenues being explored by researchers hunting for a way to beat HIV once and for all. But to many of us, the science being conducted in this area is a black box: We periodically read about study results, be they encouraging or discouraging, without understanding much of the effort behind them.
Mar. 31, 2014
Full Interview
Jeffrey Martin, M.D., M.P.H.
Featuring Jeffrey Martin, M.D., M.P.H.
A flurry of newly presented and published research seeks to peel away the remaining curtains that block a more complete understanding of Kaposi's sarcoma epidemiology and treatment.
Mar. 25, 2014
Full Interview
Jonathan Li, M.D.
Featuring Jonathan Li, M.D.
A highly respected HIV research team in Boston is conducting a study on the effect of single-pill, once-daily antiretroviral therapy on HIV-positive people who, until recently, we didn't think needed to be on treatment at all.
Mar. 11, 2014
Full Interview
Jül Gerrior-Schofield, R.D.
Featuring Jül Gerrior-Schofield, R.D.
Long overshadowed by dramatic advances in antiretroviral therapy and more medicine-oriented approaches to disease management, we frequently underappreciate the potential for dietary and nutritional interventions to improve patient treatment outcomes.
Dec. 12, 2013
Full Interview
Benjamin Young, M.D., Ph.D.
Featuring Benjamin Young, M.D., Ph.D.
Poor antiretroviral adherence is a leading cause of HIV treatment failure and the development of drug resistance. But what is the precise level of adherence that a patient needs to observe in order to ensure treatment success? Should we even aim for a specific number?
Oct. 17, 2013
Full Interview
Michael Saag, M.D.,
Michael Wong, M.D.
Featuring Michael Saag, M.D., and Michael Wong, M.D.
The Affordable Care Act: The name alone is enough to make the eyes of clinicians and patients alike glaze over. Yet the impact of the ACA (colloquially called Obamacare) has the potential to be massive when it comes to access to clinical care for HIV-infected people in the U.S.
Aug. 22, 2013
Full Interview
Douglas Dieterich, M.D.,
Daniel Fierer, M.D.
Featuring Douglas Dieterich, M.D., and Daniel Fierer, M.D.
Within a stunningly brief span of time, our understanding of HIV/hepatitis C coinfection and patient care has undergone a dramatic evolution. Two leading experts bring us up to date.
Jun. 19, 2013
Full Interview
David Alain Wohl, M.D.
Featuring David Alain Wohl, M.D.
Cardiovascular disease is, almost by definition, a major topic of concern for the HIV-positive people we count among our patients and clients -- many of whom are intimately associated with traditional cardiovascular risk factors.
Apr. 25, 2013
Full Interview

Past Interviews
Francine Cournos, M.D., and David Fawcett, Ph.D., LCSW
Mar. 14, 2013
Joel Gallant, M.D., M.P.H., and Paul Sax, M.D.
Jul. 18, 2012
Marshall Glesby, M.D., Ph.D., and Jens Lundgren, M.D.
Dec. 6, 2010
Kimberly Smith, M.D., M.P.H., and Valerie E. Stone, M.D., M.P.H.
Dec. 11, 2009
Eric Daar, M.D., and Trevor Hawkins, M.D.
Nov. 11, 2009


Copyright © 2014 Remedy Health Media, LLC. All rights reserved.


This article was provided by TheBodyPRO.com. It is a part of the publication HIV Management in Depth.